Method of preventing occlusion of arteries
AssigneeScotia Holdings PLC
InventorsDavid F. Horrobin, John C. M. Stewart
Life of this patent
Estimating the term…
Abstract
Gamma-linolenic acid and/or dihomo-gamma-linolenic acid is used in the preparation of a medicament for inhibiting reocclusion of an artery from which an occlusion or other blockage has been removed, or for preventing occlusion of peripheral or coronary arteries. The medicament may also comprise eicosapentaenoic acid.
Claims12
A method of reducing the occurrence of thrombotic and atherosclerotic occlusion of peripheral or coronary arteries by administering to a person in need of same and at risk of occlusion and of needing an angioplastic procedure, a composition comprising an effective, non-toxic amount of .gamma.-linolenic acid or dihomo-.gamma.-linolenic acid or both.
A method of reducing the occurrence of thrombotic and atherosclerotic occlusion of peripheral or coronary arteries by administering to a person in preparation for an angioplastic procedure a composition comprising an effective, non-toxic amount of .gamma.-linolenic acid or dihomo-.gamma.-linolenic acid or both.
A method of reducing the occurrence of thrombotic and atherosclerotic occlusion of peripheral or coronary arteries by administering to a person subsequent to an angioplastic procedure a composition comprising an effective, non-toxic amount of .gamma.-linolenic acid or dihomo-.gamma.-linolenic acid or both.
Dependencies are inferred from the claim text.